Key Developments and Challenges in Laboratory Networks
The current landscape of medical laboratory networks and challenges that will need to be addressed to improve data sharing and efficiency.
The Business of Testing-dtet
EC Announces New Plan to Roll Out In Vitro Diagnostic Regulation
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Hospital Laboratories Take a Stand Against Controversial UnitedHealthcare Outpatient Reimbursement Policy
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
HHS Orders FDA to Resume EUA Review of Laboratory Developed Tests for COVID-19
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Major Insurer Claims It Has No Obligation to Pay for Pooled COVID-19 Testing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Pandemic Energizes Search for Genomics-Based Early PTSD Detection Diagnostics
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
New COVID-19 Revenues Not Enough to Offset Declines in Elective & Screening Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Test Utilization: Payment Policies More Effective than Practice Recommendations in Curbing Orders of Low-Value Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Genetics Update: 23andMe Seeks to Upend the Medical Industry via Genetic Testing Information Sharing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Upfront Next-Generation Sequencing for Lung Cancer Patients Saves Time, Money
From - Diagnostic Testing & Emerging Technologies
Use of upfront next-generation sequencing (NGS) testing at diagnosis of patients with metastatic non-small-cell lung cancer (mNSCLC) is…
Guidelines at a Glance
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Preventive Genomic Screening In Young Adults Highly Cost Effective
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
From - Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…